Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation

American Heart Journal

Volumn 152, Issue 6, 2006, Pages 1104-1108

  Leong Sit, Peter ^a   Gula, Lorne J ^a   Diamantouros, Pantelis ^a   Krahn, Andrew D ^a   Skanes, Allan C ^a   Yee, Raymond ^a   Klein, George J ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEFIBRILLATION; DEFIBRILLATOR; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; TREATMENT FAILURE;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; CARDIOMYOPATHY, DILATED; DEFIBRILLATORS, IMPLANTABLE; DIFFERENTIAL THRESHOLD; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 33845220084     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.06.025     Document Type: Article

References (21)

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 (1997) 1576-1583
2. Connolly S.J., Gent M., Roberts R.S., et al. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101 (2000) 1297-1302
3. Kuck K.H., Cappato R., Siebels J., et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102 (2000) 748-754
4. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
5. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
6. Kadish A., Dyer A., Daubert J.P., et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2158
7. Marchlinski F.E., Flores B., Miller J.M., et al. Relation of the intraoperative defibrillation threshold to successful postoperative defibrillation with an automatic implantable cardioverter defibrillator. Am J Cardiol 62 (1988) 393-398
8. Gold M.R., Higgins S., Klein R., et al. Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: primary results from the Low Energy Safety Study (LESS). Circulation 105 (2002) 2043-2048
9. Joglar JA, Kessler DJ, Welch PJ, et al. Effects of repeated electrical defibrillations on cardiac troponin I levels. Am J Cardiol 83 (1999) 270-2, A6.
10. Singer I., and Lang D. Defibrillation threshold: clinical utility and therapeutic implications. Pacing Clin Electrophysiol 15 (1992) 932-949
11. Frame R., Brodman R., Furman S., et al. Clinical evaluation of the safety of repetitive intraoperative defibrillation threshold testing. Pacing Clin Electrophysiol 15 (1992) 870-877
12. Gregoratos G., Abrams J., Epstein A.E., et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol 40 (2002) 1703-1719
13. Centers for Medicare and Medicaid Services Decision Memo for Implantable Defibrillators. Medicare coverage database (online)http://www.cms.hhs.gov/mcd/viewdecisionmemo.asp?id=139 . 12-28-2004.
14. Roman-Gonzalez J., Shapiro M.L., Rubal B.J., et al. Five-year experience with implantation and follow-up of transvenous implantable cardioverter defibrillators: placing postimplant defibrillation threshold testing in perspective. Mil Med 166 (2001) 500-504
15. Gerstenfeld E.P. Defibrillation threshold testing: is one shock enough?. Heart Rhythm 2 (2005) 123-124
16. Brodsky C.M., Chang F., and Vlay S.C. Multicenter evaluation of implantable cardioverter defibrillator testing after implant: the Post Implant Testing Study (PITS). Pacing Clin Electrophysiol 22 (1999) 1769-1776
17. Vriens E.M., Bakker P.F., Vries J.W., et al. The impact of repeated short episodes of circulatory arrest on cerebral function. Reassuring electroencephalographic (EEG) findings during defibrillation threshold testing at defibrillator implantation. Electroencephalogr Clin Neurophysiol 98 (1996) 236-242
18. Theuns D.A., Szili-Torok T., and Jordaens L.J. Defibrillation efficacy testing: long-term follow-up and mortality. Europace 7 (2005) 509-515
19. Strickberger S.A., and Klein G.J. Is defibrillation testing required for defibrillator implantation?. J Am Coll Cardiol 44 (2004) 88-91
20. Russo A.M., Sauer W., Gerstenfeld E.P., et al. Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion?. Heart Rhythm 2 (2005) 456-461
21. Khalighi K., Daly B., Leino E.V., et al. Clinical predictors of transvenous defibrillation energy requirements. Am J Cardiol 79 (1997) 150-153